Oncolytics Biotech, Inc.

Contributing Author

Recent Articles by Oncolytics Biotech, Inc.

Feb-04	Oncolytics Biotech Receives FDA Fast Track Designation for Pelareorep in 2L KRAS-Mutant MSS Metastatic Colorectal Cancer ONCY GlobeNewswire
Jan-15	Oncolytics Biotech Announces Results of Special Meeting of Shareholders ONCY -7.33% GlobeNewswire
Jan-14	Oncolytics Biotech Appoints John McAdory as EVP of Strategy and Operations and Yujun Wu to Lead Biostatistics ONCY GlobeNewswire
Jan-12	Oncolytics Biotech Announces Updated Clinical Data from GOBLET Cohort 4 Demonstrating Activity of Pelareorep Plus Atezolizumab in Third-Line Anal Cancer ONCY GlobeNewswire
Jan-09	Oncolytics Biotech Outlines Strategic Rationale for Proposal to Change Jurisdiction of Incorporation to Nevada ONCY GlobeNewswire